or Try an Advanced Search...

    Technical Analysis for PMVP - PMV Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    D 1.60 -2.14% -0.04
    PMVP closed down 8.66 percent on Monday, April 15, 2024, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical PMVP trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish -2.14%
    Fell Below 50 DMA Bearish -2.14%
    Expansion Pivot Sell Setup Bearish Swing Setup -2.14%
    Crossed Above 20 DMA Bullish -10.61%
    Crossed Above 50 DMA Bullish -10.61%
    MACD Bullish Signal Line Cross Bullish -10.61%
    Expansion Pivot Buy Setup Bullish Swing Setup -10.61%
    Pocket Pivot Bullish Swing Setup -10.61%
    Gapped Up Strength -10.61%
    Stochastic Buy Signal Bullish 1.27%
    Older End-of-Day Signals for PMVP ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 2 hours ago
    10 DMA Resistance about 2 hours ago
    Fell Below 10 DMA about 2 hours ago
    60 Minute Opening Range Breakout about 4 hours ago
    10 DMA Support about 6 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    PMVP Chart by TradingView
    Basic chart:

    Profile

    PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Biology Cell Biology Proteins Apoptosis P53 Tumor Suppressor Genes

    Is PMVP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 27 PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
    Mar 18 PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer
    Mar 1 PMV Pharmaceuticals reports FY results
    Mar 1 PMV Pharmaceuticals Inc (PMVP) Reports Full Year 2023 Financial Results
    Feb 29 PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
    Feb 26 PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference
    Jan 18 PMV to focus on lead drug, slashes workforce by 30%
    Jan 18 PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway
    Jan 5 PMV Pharmaceuticals names Michael Carulli as CFO
    Jan 5 PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development
    See more PMVP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.71
    52 Week Low 1.175
    Average Volume 612,940
    200-Day Moving Average 3.72
    50-Day Moving Average 1.70
    20-Day Moving Average 1.66
    10-Day Moving Average 1.63
    Average True Range 0.13
    RSI (14) 47.64
    ADX 12.77
    +DI 24.48
    -DI 20.56
    Chandelier Exit (Long, 3 ATRs) 1.46
    Chandelier Exit (Short, 3 ATRs) 1.87
    Upper Bollinger Bands 1.81
    Lower Bollinger Band 1.51
    Percent B (%b) 0.4
    BandWidth 17.96
    MACD Line -0.03
    MACD Signal Line -0.04
    MACD Histogram 0.0044
    Fundamentals Value
    Market Cap 83.64 Million
    Num Shares 51.2 Million
    EPS -1.56
    Price-to-Earnings (P/E) Ratio -1.05
    Price-to-Sales 0.00
    Price-to-Book 0.36
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.94
    Resistance 3 (R3) 1.96 1.89 1.89
    Resistance 2 (R2) 1.89 1.81 1.87 1.87
    Resistance 1 (R1) 1.76 1.76 1.72 1.74 1.85
    Pivot Point 1.69 1.69 1.67 1.67 1.69
    Support 1 (S1) 1.56 1.61 1.52 1.54 1.42
    Support 2 (S2) 1.49 1.56 1.47 1.40
    Support 3 (S3) 1.36 1.49 1.39
    Support 4 (S4) 1.34